Immunodiagnostic Systems Holdings PLC
- Home
- Companies
- Immunodiagnostic Systems Holdings PLC
- Products
- IDS LISA-TRACKER - Model LTTR-003-48 / ...
IDS LISA-TRACKER - Model LTTR-003-48 / LTTR-003-96 -Anti-Trastuzumab Manual Immunoassays
LISA-TRACKER anti-Trastuzumab is an enzyme linked immunoassay (ELISA) for the quantitative determination of anti-Trastuzumab antibodies in human serum samples.
Most popular related searches
epidermal growth factor receptor 2
therapeutic drug monitoring
immunoassay
epidermal growth
drug monitoring
immunoassay ELISA
human serum
gastric cancer
monoclonal antibody
therapeutic drug
Trastuzumab is a humanised monoclonal antibody that reduces cell proliferation by inhibiting Human Epidermal growth factor Receptor-2 (HER2). It is indicated for the treatment of metastatic breast gastric cancers which typically over-express HER2. It functions to prevent the action of the HER2 which is responsible for the cell proliferation. During the treatment, some patients can develop antibodies against Trastuzumab.
- Comprehensive menu in inflammatory diseases and oncology
- Validated on principle drug and biosimilars
- Ready to use reagents
- Standardised protocols from sample collection to result interpretation
- Automation ready – validated on several open platform ELISA systems
- Product Code: LTTR-003-48 / LTTR-003-96
- Allergen Type: Manual
- Certification: CE Marked
- Clinical Area: Therapeutic Drug Monitoring Solutions
- Type: Manual
- Format: ELISA
- RUO/IVD: IVD
- Number of Tests: 48 or 96
- Sample Type: Serum
- Sample Volume: 100 μL (following predilution)
- Assay Range: 10 – 120 ng/mL